We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,261 results
  1. Pharmaco-EEG analysis of ligands varying in selectivity for α1 subunit-containing GABAA receptors during the active phase in rats

    Rationale

    Benzodiazepines are known to evoke changes in cortical electrophysiological activity that can be correlated with action at distinct...

    Jaren A. Reeves-Darby, Lais F. Berro, ... James K. Rowlett in Psychopharmacology
    Article 22 August 2023
  2. PBPK Analysis to Study the Impact of Genetic Polymorphism of NAT2 on Drug-Drug Interaction Potential of Isoniazid

    Purpose

    Isoniazid (INH) is prescribed both for the prophylaxis as well as the treatment of tuberculosis. It is primarily metabolized through...

    Ankit Balhara, Saranjit Singh in Pharmaceutical Research
    Article 13 September 2021
  3. Exploring gender differences in pharmacokinetics of central nervous system related medicines based on a systematic review approach

    Due to the inevitable differences in physiological and/or genetic factors between genders, the possibility that differences in pharmacokinetics...

    Seung-Min Lee, Ji-Hun Jang, Seung-Hyun Jeong in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 08 June 2024
  4. Induction of CYP3A activity by dexamethasone may not be strong, even at high doses: insights from a case of tacrolimus co-administration

    Background

    Dexamethasone (DEX) induces CYP3A activity in a concentration-dependent manner. However, no study has examined changes in the blood...

    Yoshiyuki Ohno, Toyohito Oriyama, ... Tappei Takada in Journal of Pharmaceutical Health Care and Sciences
    Article Open access 04 December 2023
  5. Characterization and Applications of Permeabilized Hepatocytes in Drug Discovery

    Hepatocytes are one of the most physiologically relevant in vitro liver systems for human translation of clearance and drug-drug interactions (DDI)....

    Sam Zhang, Christine C. Orozco, ... Li Di in The AAPS Journal
    Article 28 March 2024
  6. In Silico Prediction of Pharmacokinetic Profile for Human Oral Drug Candidates Which Lack Clinical Pharmacokinetic Experiment Data

    Backgrounds and Objectives

    In silico methods which can generate high-quality physiologically based pharmacokinetic (PBPK) models for arbitrary drug...

    **gchen Zhai, Beihong Ji, ... Junmei Wang in European Journal of Drug Metabolism and Pharmacokinetics
    Article 16 February 2022
  7. Management of chronic insomnia using hypnotics: a friend or a foe?

    Epidemiological studies suggest that 10–15% adults meet the present criteria for the diagnosis of insomnia disorder; however, there may be...

    Aniruddha Basu, Tanmay Joshi, ... Ravi Gupta in Sleep and Biological Rhythms
    Article 09 January 2022
  8. Cannabinoid Interactions with Cytochrome P450 Drug Metabolism: a Full-Spectrum Characterization

    Medicinal cannabis use has increased exponentially with widespread legalization around the world. Cannabis-based products are being used for numerous...

    Peter T. Doohan, Lachlan D. Oldfield, ... Lyndsey L. Anderson in The AAPS Journal
    Article 28 June 2021
  9. Benzodiazepines in Alzheimer’s disease: beneficial or detrimental effects

    Dementia is considered a clinical syndrome characterized by cognitive dysfunction and memory loss. Alzheimer's disease (AD) is the most common type...

    Hayder M. Al-kuraishy, Ali I. Al-Gareeb, ... Gaber El-Saber Batiha in Inflammopharmacology
    Article 23 November 2022
  10. Sleep in Space Environment

    Sleep deprivation on Earth may impair cognitive performance. As a result, poor mental alertness, attention, and vigilance may lead to fatal...
    Poornima Ramburrun, Shivani Ramburrun, Yahya E. Choonara in Handbook of Space Pharmaceuticals
    Living reference work entry 2022
  11. Sleep in Space Environment

    Sleep deprivation on Earth may impair cognitive performance. As a result, poor mental alertness, attention, and vigilance may lead to fatal...
    Poornima Ramburrun, Shivani Ramburrun, Yahya E. Choonara in Handbook of Space Pharmaceuticals
    Reference work entry 2022
  12. Postmortem Toxicology: A Facet of Drugs to Expedite Crimes

    Postmortem toxicology is a branch of forensic toxicology that helps in establishing the impact or role of poisonous substances in the death of an...
    Shipra Rohatgi, Pooja Yadav, Dina Shokry in Crime Scene Management within Forensic Science
    Chapter 2022
  13. Synergistic Herb-Drug Interactions in Neurological Disorders

    The incidence of neurological disorders of the brain, spine, and nervous system including Alzheimer’s disease (AD), stroke, dementia, epilepsy, and...
    Shanmugam Hemaiswarya, Pranav Kumar Prabhakar, Mukesh Doble in Herb-Drug Combinations
    Chapter 2022
  14. Serum 4β-hydroxycholesterol increases during fluconazole treatment

    Purpose

    The antifungal drugs ketoconazole and itraconazole reduce serum concentrations of 4β-hydroxycholesterol, which is a validated marker for...

    Dieter Lütjohann, Frans Stellaard, ... Bruno G Oertel in European Journal of Clinical Pharmacology
    Article Open access 17 November 2020
  15. Clinical Effects of Piracetam Plus Mannitol on Cerebral Edema, Neurological Function, and Vascular Endothelin-1 Levels Following Cerebral Hemorrhage

    Abstract

    The effects of piracetam plus mannitol on cerebral edema, neurological function, and vascular endothelin-1 (ET-1) levels after cerebral...

    Tingyan Hu, Yi Zhao, ... Chenghai Zuo in Neurochemical Journal
    Article 01 March 2023
  16. Sleep During Hypnotic Therapy

    Insomnia is a significant public health burden with a prevalence rate of 5–50% in the general population. Evidence indicates that histaminergic,...
    Chapter 2022
  17. Hypnotics and Sedatives

    Sleep is an active physiological process which harmonizes the brain function. A sedative is a drug which reduces activity and alertness by producing...
    Chapter 2021
  18. Evaluation of Time-Dependent Cytochrome P450 Inhibition Using the Area Under the Curve Shift Method

    New molecular entities (NMEs) causing time-dependent inhibition (TDI) of cytochrome P450 (CYP) enzymes are a concern because they can be responsible...
    Julie Huang in Cytochrome P450
    Protocol 2021
  19. Pharmacological Management of Insomnia

    Insomnia is a highly prevalent condition associated with significant morbidity, reduction in quality of life, and increase in healthcare costs, and...

    Sarika Madari, Raphael Golebiowski, ... Bhanu Prakash Kolla in Neurotherapeutics
    Article 01 January 2021
  20. The Necessity of Using Changes in Absorption Time to Implicate Intestinal Transporter Involvement in Oral Drug-Drug Interactions

    Introduction

    In drug discovery and development, it is of high interest to characterize the potential for intestinal drug-drug interactions to alter...

    Jasleen K. Sodhi, Leslie Z. Benet in The AAPS Journal
    Article 17 August 2020
Did you find what you were looking for? Share feedback.